Lundbeck
Pharmaceutical ManufacturingHovedstaden, Denmark5001-10000 Employees
Lundbeck is a biopharmaceutical company dedicated to brain health, with more than seven decades of experience in neuroscience. It develops medicines aimed at neurological and psychiatric conditions, pursuing treatments for patients who have few or no alternatives and expanding into neuro-specialty and neuro-rare areas beyond its psychiatry and neurology heritage. Headquartered in Copenhagen, it maintains a global presence across more than 20 countries. Its products are available in over 80 countries and are used by healthcare professionals to address brain disorders that affect patients and their families. The company serves clinicians, patients, and caregivers by expanding treatment options where needs remain unmet. In early 2026, Lundbeck announced the promotion of Markus Kede to Senior Vice President and Chief AI Officer, reflecting a strengthened focus on applying artificial intelligence across research and commercial activities.
1-888-653-2347 
support@leadiq.com 
